Indian Vaccine Maker Bharat Biotech Is Said to Mull $500 Million IPO
Indian vaccine developer Bharat Biotech International Ltd. is considering an initial public offering that may raise more than $500 million, according to people familiar with the matter.
📰 Original Source
Read full article at Bloomberg →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.